{
    "nctId": "NCT04019678",
    "briefTitle": "Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes.",
    "officialTitle": "Breast Carcinoma T1-T2-T3 / cN +: Axillary Conservation of Lymph Nodes in the Presence of Micro Metastases in Sentinel Lymph Node, in cN- After Neoadjuvant Chemotherapy - Studio NEONOD 2",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 850,
    "primaryOutcomeMeasure": "Disease-free or death-free survival for any reason (DFS)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age: 18 \u226475 years\n2. Breast carcinoma with infiltrating histotype\n3. Tumor size: cT1 - cT2 - cT3\n4. Positive axillary lymph nodes (cN +) at the initial diagnosis by clinical, ultrasound and cyto-microhistology evaluation\n5. Neoadjuvant chemotherapy performed\n6. Negative axillary lymph nodes (cN-) from the NAC by clinical and ultrasound assessment\n7. Absence of distant metastases (M0)\n8. Negative medical history for previous infiltrating breast cancer\n\nExclusion Criteria:\n\n1. Current pregnancy or lactation status\n2. Inflammatory breast cancer\n3. In situ breast cancer\n4. Synchronous contralateral breast cancer\n5. Co-morbidity and/or medical disorder precluding any adjuvant therapy\n6. Co-morbidity and/or medical/mental disorder making impossible making a regular follow-up\n7. Other cancers in the previous 3 years (except forcarcinoma in situ of the uterine cervix, basalioma, squamous cell carcinoma or non-melanoma skin cancer)",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}